Groundbreaking: First-Ever HCC RAF Score Accessible Through REST API
First-Ever HCC RAF Score Accessible Through REST API
Check Now
Image depicting the concept of elevating provider support and enhancing concurrent coding for risk adjustment in healthcare.
Elevate Provider Support:
Enhance Your Concurrent Coding
for Risk Adjustment
Check Now

ICD-10-CM Diagnosis Code E88.3

Effective Date: 10/01/2015 To 09/30/2025

Tumor lysis syndrome

CMS-HCC-V24 CMS-HCC-V28 RxHCC Age Gender Maternity Acute or Chronic MCC
-- -- -- -- -- -- Acute Yes
Applicable To for E88.3:
  • Tumor lysis syndrome (spontaneous)

  • Tumor lysis syndrome following antineoplastic drug chemotherapy

Use Additional for E88.3:
  • code for adverse effect, if applicable, to identify drug (T45.1X5)

Back-references to E88.3
  • Syndrome see also Disease
    • tumor lysis(following antineoplastic chemotherapy) (spontaneous) NEC E88.3
    • Tumor lysis syndrome(following antineoplastic chemotherapy) (spontaneous) NEC E88.3
    • Related Medications for E88.3
      • allopurinol, rasburicase

      Chapter, Section and Diagnosis Prefix for E88.3
        E00-E89 :

        Endocrine, nutritional and metabolic diseases

        E70-E88 :

        Metabolic disorders

        E88 :

        Other and unspecified metabolic disorders